期刊的影响因子--文章列表

期刊文章列表
Yuqian Chen¹，Zhen Hua¹，Fan Lin²，Tiantian Zheng³，Heng Zhou¹，Shijie Zhang²，Jing Gao²，Zhongyi Wang²，Huafei Shao²，Wenjuan Li²，Fengjie Liu²，Simin Wang⁴，Yan Zhang⁵，Feng Zhao⁶，Hao Liu⁷，Haizhu Xie²，Heng Ma²，Haicheng Zhang^2,8，Ning Mao^2,8（School of Information and Electronic Engineering,Shandong Technology and Business University；Department of Radiology,Yantai Yuhuangding Hospital,Affiliated Hospital of Qingdao University；School of Medical Imaging,Binzhou Medical University；Department of Radiology,Fudan University Cancer Center；Department of Radiology,Guangdong Maternal and Child Health Hospital；School of Computer Science and Technology,Shandong Technology and Business University；Yizhun Medical AI Co.Ltd.；Big Data and Artificial Intelligence Laboratory,Yantai Yuhuangding Hospital,Affiliated Hospital of Qingdao University）.Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system：A multicenter study[J].Chinese Journal of Cancer Research,2023,第4期 Zhaohong An¹，Wan Liu²，Wenbin Li³，Minghui Wei²，Changming An¹（Department of Head & Neck Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Head & Neck Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Shenzhen Center；Department of Pathology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College）.Application of single-cell RNA sequencing in head and neck squamous cell carcinoma[J].Chinese Journal of Cancer Research,2023,第4期 Boshi Wang，Wei Hu，Xue Zhang，Yanchao Cao，Lin Shao，Xiaodong Xu，Peng Liu（Department of Clinical Nutrition,Peking University People’s Hospital；Peking University People’s Hospital,Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease）.Sarcopenia and gut microbiota alterations in patients with hematological diseases before and after hematopoietic stem cell transplantation[J].Chinese Journal of Cancer Research,2023,第4期 Jianguo Wang^1,2，Xiaonan Xiang²，Zhixiong Shi²，Hui Zhang²，Quanbao Zhang³，Zhikun Liu^1,2，Guangjie Zhao⁴，Chuanxing Wu⁵，Qiang Wei^1,2，Lin Zhong⁵，Zhengxin Wang³，Guoyue Lv⁴，Shusen Zheng^6,7，Xiao Xu^1,2,6（Department of Hepatobiliary and Pancreatic Surgery,Affiliated Hangzhou First People’s Hospital,Zhejiang University School of Medicine；Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province；Department of General Surgery,Huashan Hospital,Fudan University；Department of Hepatobiliary and Pancreatic Surgery,the First Bethune Hospital of Jilin University；Department of Hepatobiliary and Pancreatic Surgery,Shanghai General Hospital；Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital,Zhejiang University School of Medicine；Department of Hepatobiliary and Pancreatic Surgery,Shulan (Hangzhou) Hospital,Zhejiang Shuren University School of Medicine）.Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence[J].Chinese Journal of Cancer Research,2023,第4期 Mi Mi¹，Shanshan Weng¹，Ziheng Xu¹，Hanguang Hu¹，Yi Wang，Ying Yuan^1,3,4（Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention,China National Ministry of Education,Key Laboratory of Molecular Biology in Medical Sciences,Zhejiang Province,China),The Second Affiliated Hospital,Zhejiang University School of Medicine；Department of Radiology,Peking University People’s Hospital；Zhejiang Provincial Clinical Research Center for CANCER；Cancer Center,Zhejiang University）.CSCO guidelines for colorectal cancer version 2023: Updates and insights[J].Chinese Journal of Cancer Research,2023,第3期 Shasha Liu^1,2，Yi Zhang^1,2,3,4（Biotherapy Center,the First Affiliated Hospital of Zhengzhou University；Cancer Center,the First Affiliated Hospital of Zhengzhou University；State Key Laboratory of Esophageal Cancer Prevention &Treatment,Zhengzhou University；Henan Key Laboratory for Tumor Immunology and Biotherapy）.Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors[J].Chinese Journal of Cancer Research,2023,第3期 Gangjian Wang¹，Xin Ji²，Haojie Wang³，Xiaohuan Tang¹，Xiaofang Xing¹，Jiafu Ji^1,2（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gastrointestinal Cancer Translational Research Laboratory,Peking University Cancer Hospital &Institute；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital &Institute；Institute of Genetics and Developmental Biology,Chinese Academy of Sciences）.PTPRD/PTPRT mutation correlates to treatment outcomes of immunotherapy and immune landscape in pan-cancers[J].Chinese Journal of Cancer Research,2023,第3期 Gaoyuan Yang¹，Huamei Yan²，Yongchang Tang³，Feng Yuan⁴，Mingbo Cao¹，Yupeng Ren¹，Yuxuan Li¹，Zhiwei He¹，Xiaorui Su⁵，Zhicheng Yao⁵，Meihai Deng¹（Department of Hepatobiliary Surgery,The Third Affiliated Hospital,Sun Yat-sen University；Department of Radiation Oncology,The Third Affiliated Hospital,Sun Yat-sen University；Department of General Surgery,Qilu Hospital,Shandong University；Department of General Surgery,The First Affiliated Hospital,Guangzhou Medical University；Department of Hepatobiliary and Pancreatic Surgery,The Third Affiliated Hospital,Sun Yat-sen University）.Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review[J].Chinese Journal of Cancer Research,2023,第3期 Beibei Pei¹，Xiaoyan Ma¹，Na Wu¹，Chen Wang²，Wenhui Yang³（Third Hospital of Shanxi Medical University,Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital；Shanxi Medical University；Department of Gastroenterology,Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital,Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University）.Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors[J].Chinese Journal of Cancer Research,2023,第3期 Cunte Chen，Yangqiu Li²（Department of Hematology,Guangzhou First People’s Hospital,School of Medicine,South China University of Technology；Institute of Hematology,School of Medicine,Key Laboratory for Regenerative Medicine of Ministry of Education,Jinan University）.Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies[J].Chinese Journal of Cancer Research,2023,第3期 Qi Cao¹，Ruidong Xue¹，Ning Zhang^1,2,3（Translational Cancer Research Center,Peking University First Hospital；International Cancer Institute,Peking University Health Science Center；Yunnan Baiyao Group）.Th1 cells inducing IFNγ response improves immunotherapy efficacy in gastric cancer[J].Chinese Journal of Cancer Research,2023,第3期 National Health Commission of the People’s Republic of China，Society of Oncology，Chinese Medical Association.National Health Commission guidelines for diagnosis andtreatment of colorectal cancer 2023 in China (English version)[J].Chinese Journal of Cancer Research,2023,第3期 Jinjin Zhang^1,2，Feifei Guo¹，Lingyu Li¹，Songling Zhang³，Yufeng Wang¹（Cancer Center,The First Hospital of Jilin University；Department of Gynecology,Obstetrics and Gynecology Center,The First Hospital of Jilin University；Department of Gynecological Oncology,Obstetrics and Gynecology Center,The First Hospital of Jilin University）.Immune evasion and therapeutic opportunities based on natural killer cells[J].Chinese Journal of Cancer Research,2023,第3期 Cao Qi，Xue Ruidong，Zhang Ning.Th1 cells inducing IFNgamma response improves immunotherapy efficacy in gastric cancer[J].中国癌症研究,2023,第3期 Xinxin Yan¹，Lin Lei²，He Li¹，Maomao Cao¹，Fan Yang¹，Siyi He¹，Shaoli Zhang¹，Yi Teng¹，Qianru Li¹，Changfa Xia¹，Wanqing Chen¹（Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Cancer Prevention and Control,Shenzhen Center for Chronic Disease Control）.Stomach cancer burden in China：Epidemiology and prevention[J].Chinese Journal of Cancer Research,2023,第2期 Qian Guan^1,2，Huiran Lin³，Wenfeng Hua⁴，Lei Lin¹，Jiabin Liu¹，Linqing Deng¹，Jiao Zhang⁵，Jiwen Cheng，Zhonghua Yang⁷，Yong Li，Jun Bian，Haixia Zhou，Suhong Li¹¹，Li Li，Lei Miao¹，Huimin Xia¹，Jing He^1,2，Zhenjian Zhuo^1,2,13（School of Medicine,South China University of Technology；Department of Pediatric Surgery,Guangzhou Institute of Pediatrics,Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease,Guangdong Provincial Clinical Research Center for Child Health,Guangzhou Women and Children’s Medical Center,Guangzhou Medical University；Faculty of Medicine,Macau University of Science and Technology；Research Institute for Maternal and Child Health,Guangdong Second Provincial General Hospital；Department of Pediatric Surgery,the First Affiliated Hospital of Zhengzhou University；Department of Pediatric Surgery,the Second Affiliated Hospital of Xi’an Jiaotong University；Department of Pediatric Surgery,Shengjing Hospital of China Medical University；Department of Pediatric Surgery,Hunan Children’s Hospital；Department of General Surgery,Xi’an Children’s Hospital,Xi’an Jiaotong University Affiliated Children’s Hospital；Department of Hematology,The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University；Department of Pathology,Children Hospital and Women Health Center of Shanxi；Kunming Key Laboratory of Children Infection and Immunity,Yunnan Key Laboratory of Children’s Major Disease Research,Yunnan Institute of Pediatrics Research,Yunnan Medical Center for Pediatric Diseases,Kunming Children’s Hospital；Laboratory Animal Center,School of Chemical Biology and Biotechnology,Peking University Shenzhen Graduate School）.Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression[J].Chinese Journal of Cancer Research,2023,第2期 Mingjie Jiang¹，Dianna Gu²，Furao Liu³，Chenjing Lin⁴，Ling Tian⁴（Department of Head and Neck Surgery,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine；Department of Chemotherapy,the First Affiliated Hospital of Wenzhou Medical University；Shanghai Key Laboratory of Pancreatic Diseases,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine；Department of Central Laboratory,Shanghai Chest Hospital,Shanghai Jiao Tong University School of Medicine）.Transforming cancer cells for long-term living with cancer：An inspiring new approach[J].Chinese Journal of Cancer Research,2023,第2期 Yufeng Gu^1,2,3，Shengjun Xu^2,4，Zhengxin Wang⁵，Jiayin Yang⁶，Shusen Zheng^7,8，Qiang Wei^2,4，Zhikun Liu^2,4，Xiao Xu^1,2,3,9（The Fourth School of Clinical Medicine,Zhejiang Chinese Medical University；Department of Hepatobiliary and Pancreatic Surgery,Affiliated Hangzhou First People’s Hospital,Zhejiang University School of Medicine；Institute of Organ Transplantation,Zhejiang University；Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province；Department of General Surgery,Huashan Hospital,Fudan University；Department of Liver Surgery,Liver Transplantation Center,West China Hospital of Sichuan University；Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital,Zhejiang University School of Medicine；Department of Hepatobiliary and Pancreatic Surgery,Shulan (Hangzhou) Hospital；Westlake Laboratory of Life Sciences and Biomedicine）.When immunotherapy meets liver transplantation for hepatocellular carcinoma：A bumpy but promising road[J].Chinese Journal of Cancer Research,2023,第2期 Xiangping Wu¹，Qingnan Wu²，Yan Wang²，Yehai Liu¹，Zhenhao Li³，Qingchuan Liu⁴，Zhengming Huang⁴，Mingyan Li³，Bin Zhang^1,5，Qimin Zhan²（Department of Otolaryngology-Head &Neck Surgery,The First Affiliated Hospital of Anhui Medical University；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Laboratory of Molecular Oncology,Peking University Cancer Hospital &Institute；Zhejiang Shouxiangu Pharmaceutical Co.Ltd；Beijing Weijian Jiye Institute of Biotechnology；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Head and Neck Surgery,Peking University Cancer Hospital &Institute）.Aqueous-soluble components of sporoderm-removed Ganoderma lucidum spore powder promote ferroptosis in oral squamous cell carcinoma[J].Chinese Journal of Cancer Research,2023,第2期 Zejiang Zhan¹，Yingying Huang¹，Jiayu Zhou¹，Zhuochen Cai¹，Haoyang Huang¹，Ying Deng¹，Wenze Qiu²，Xun Cao³，Xi Chen¹，Chixiong Liang¹，Lulu Zhang¹，Xiang Guo¹，Taize Yuan⁴，Xing Lyu¹（Department of Nasopharyngeal Carcinoma,Sun Yat-sen University Cancer Center,the State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy；Department of Radiation Oncology,Affiliated Cancer Hospital and Institute of Guangzhou Medical University；Department of Critical Care Medicine,Sun Yat-sen University Cancer Center,the State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine；Department of Radiation Oncology,Guangzhou Concord Cancer Center）.Integrated strategies for chemotherapy cycles in nasopharyngeal carcinoma patients：Real-world data from two epidemic centers guiding decision-making[J].Chinese Journal of Cancer Research,2023,第2期 Yinkui Wang¹，Fanling Hong^1,2，Shuangxi Li¹，Fei Shan¹，Yongning Jia¹，Rulin Miao¹，Zhemin Li¹，Ziyu Li¹，Jiafu Ji¹（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital &Institute；Endoscopy Center,Zhongshan Hospital,Fudan University (Xiamen Branch)）.Exploration and optimization of surgical techniques for laparoscopic transhiatal lower mediastinal lymph node dissection for adenocarcinoma of esophagogastric junction：A prospective IDEAL 2a study with qualitative design[J].Chinese Journal of Cancer Research,2023,第2期 Asian Institute of Clinical Oncology (AICO) Expert Panel.Adjuvant therapy for hormone receptor-positive breast cancer：Perspective from a survey on breast cancer physicians’ acceptance of practice-changing data[J].Chinese Journal of Cancer Research,2023,第2期 Nan Chen¹，Jaffer A Ajani²，Aiwen Wu¹（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital &Institute；Department of Gastrointestinal Medical Oncology,The University of Texas MD Anderson Cancer Center）.Nonoperative management of gastrointestinal malignancies in era of neoadjuvant treatment[J].中国癌症研究(英文版),2023,第1期 Aiping Huang¹，Wenhu Zhou^1,2（Xiangya School of Pharmaceutical Sciences,Central South University；Changsha Medical University,Academician Workstation）.Mn-based cGAS-STING activation for tumor therapy[J].中国癌症研究(英文版),2023,第1期 Maomao Cao¹，Jufang Shi¹，Changfa Xia¹，He Li¹，Wei Cai²，Xianyun Qi³，Chunyun Dai⁴，Wanqing Chen¹（Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Prevention and Control of Chronic Noncommunicable Diseases,Binhai County Center for Disease Control and Prevention；Chronic Noncommunicable Diseases Prevention and Treatment Department,Yingdong District Center for Disease Control and Prevention；Department for Chronic Noncommunicable Diseases Control,Sheyang Center for Disease Control and Prevention）.Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: Amulticenter diagnostic trial[J].中国癌症研究(英文版),2023,第1期 Huigang Li^1,2,3,4，Zuyuan Lin^1,2,3,4，Jianyong Zhuo^1,2,3,4，Modan Yang^1,2,3,4，Wei Shen^1,2,3,4，Zhihang Hu^1,2,3,4，Yichen Ding¹，Hao Chen^1,2,3,4，Chiyu He^1,2,3,4，Xinyu Yang^1,2,3,4，Siyi Dong⁵，Xuyong Wei^1,2,3,4，Beicheng Sun⁶，Shusen Zheng^4,5,7,8,9，Ren Lang¹⁰，Di Lu^1,2,3,4，Xiao Xu^1,3,4,5（Zhejiang University School of Medicine；Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province,Department of Hepatobiliary and Pancreatic Surgery,Affiliated Hangzhou First People’s Hospital,Zhejiang University School of Medicine；The Institute for Organ Repair and Regenerative Medicine of Hangzhou；Institute of Organ Transplantation,Zhejiang University；National Center for Healthcare Quality Management in Liver Transplant；Department of Hepatobiliary Surgery,the Affiliated Drum Tower Hospital of Nanjing University Medical School；Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital,Zhejiang University School of Medicine；Department of Hepatobiliary and Pancreatic Surgery,Shulan (Hangzhou) Hospital；NHC Key Laboratory of Combined Multi-organ Transplantation；Department of Hepatobiliary Surgery,Beijing Chaoyang Hospital Affiliated to Capital Medical University）.TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma[J].中国癌症研究(英文版),2023,第1期 Wei Liu，Ziyang Wu，Tong Sun，Shuyao Liang，Jun Zhu，Suodi Zhai，Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society，Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association，Oncology Society of Chinese Medical Association，Nursing Branch of China International Exchange and Promotive Association for Medical and Healthcare，Division of Drug-induced Diseases of Chinese Pharmacology Society（Department of Pharmacy,Peking University Third Hospital；Institute for Drug Evaluation,Peking University Health Science Center；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Lymphoma,Peking University Cancer Hospital &Institute）.Management guidelines for preventing exposure to antineoplastics[J].中国癌症研究(英文版),2023,第1期首页上一页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表